Ken Jones appointed head of Astellas Europe
April 13, 2011Astellas, Ken Jones
Astellas has appointed Ken Jones as its president and chief executive in Europe. Jones had been the chief operating officer …
Novartis ends phase III trial of Tasigna
April 12, 2011GIST, Glivec, Novartis, Tasigna
Novartis has stopped a late stage study of Tasigna for certain types of stomach cancers after it failed to show …
Free Pharmacovigilance Training Webinar
April 12, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Wainwright Associates are offering you the opportunity to attend a FREE thirty minute webinar on “The roles and responsibilities of …
NZ firm seeks European partners to make heart drug ingredient
April 12, 2011Manufacturing and Production Photonz Corp, contract manufacturing
A small New Zealand company is trying to find European contract manufacturing partners to help it scale up production of …
Indian firm Dr Reddy’s opens UK site
April 12, 2011Sales and Marketing Cambridge, Chirotech, Dr Reddy's, India, generics
Indian firm Dr Reddy’s has confirmed the UK is still attractive for investment as it opens its new pharma services …
Merck teams up with Sun on emerging markets generics
April 12, 2011Sales and Marketing India, Merck, Sun Pharma, emerging markets
Merck Inc has created a joint venture with Indian firm Sun Pharmaceutical Industries to develop, manufacture and market branded generics …
Growth spurt prompts new facility for Cherwell
April 11, 2011Manufacturing and Production Cherwell Laboratories, environmental monitoring products, microbiological media
Cherwell Laboratories of the UK has opened a new manufacturing and warehousing facility for its microbiological media and environmental monitoring …
GSK pilots wireless sensors to improve plant efficiency
April 11, 2011Manufacturing and Production API, GSK, Ireland
GlaxoSmithKline has started pilot testing of a wireless system of flow and pressure transmitters to try to improve the efficiency …
Bayer drug enters phase III for diabetic macular oedema
April 11, 2011Sales and Marketing Bayer, Lucentis, ophthalmology
Bayer and partner Regeneron have begun late stage trials for their VEGF Trap Eye candidate for diabetic macular oedema. The …
GSK and Valeant’s epilepsy treatment approved
April 8, 2011Sales and Marketing GSK, Trobalt, Valeant, epilepsy
The European Commission has granted marketing authorisation for Trobalt, the new epilepsy drug from GSK and Valeant. Trobalt (retigabine) has …
Eisai sets up in Brazil
April 8, 2011Sales and Marketing Brazil, Eisai
Japanese pharma company Eisai has set up its first operations in Latin America, establishing a sales subsidiary in Brazil. Based …
Lane, Earl & Cox acquired by Open Health
April 8, 2011Medical Communications Chime Communications, Lane Earl Cox, Open Health
Chime’s newly-launched healthcare comms shop Open Health has bought established UK health advertising agency Lane, Earl & Cox. It will …
AZ gets green light for thyroid cancer drug
April 7, 2011Sales and Marketing AstraZeneca, zactima
AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …
‘Listening exercise’ to re-shape NHS reforms
April 7, 2011Health and Social Care Bill, NHS, NHS reform
The government has paused its reforms of the NHS and launched what it calls a ‘listening exercise’ to regain support …
HRW promotes Gillian Newbold to the board
April 7, 2011Medical Communications apppointment, medical communications
Healthcare research agency HRW has promoted Gillian Newbold to its board of directors. Gillian joined the Oxfordshire, UK-based company in …
Working Life: Merck Serono’s Wolfgang Wein
April 6, 2011Research and Development, Sales and Marketing Working Life
Head of oncology at Merck Serono Wolfgang Wein explains how his field is changing, the best thing about his role …
John Gargiulo to lead Daiichi Sankyo in the US
April 6, 2011Sales and Marketing appointment, sales and marketing
Daiichi Sankyo has appointed John Gargiulo as its president and chief executive in the US. He succeeds Joseph Pieroni who …
Evil big pharma: myth or material?
April 6, 2011Research and Development, Sales and Marketing Les Rose, industry reputation
In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …
Merck acquires eyecare specialist Inspire
April 6, 2011Research and Development, Sales and Marketing Inspire, Merck, eye care
Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …
Boehringer bets on Pradaxa to fill portfolio gaps
April 6, 2011Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa
Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
